Rudolf Valenta

This inventor holds 36 USPTO granted patents and 16 published patent applications, plus 12 CIPO patents and 12 EPO patents, primarily in Allergy Immunotherapy. Top assignees: Biomay Ag, Phadia Ab, Biomay Produktions- Und Handelsgesellschaft M.b.h.. Active years: 1996-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rudolf Valenta. Retrieved from https://idiyas.com/inventor/rudolf-valenta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 36 (Patent Applications = 16)

% Patents Active = 63.9

CIPO Patents = 12 (Patent Applications = 1)

EPO Patents = 12 (Patent Applications = 30)

Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 68(Granted Patents)

Location History:

AT-2604 Theresienfeld, AT (2003)
A-2604, Theresienfeld, AT (2007)
Vienna, AT (2006 - 2011)
Theresienfeld, AT (1996 - 2023)

Company Filing History:

Biomay Produktions- Und Handelsgesellschaft M.b.h.

patents

4. 2 out of 4

Biomay Produktions- Und Handelsaktiengesellschaft

patents

5. 2 out of 16

Pharmacia Diagnostics Ab

Biomay Biotechnik Produktions Und Handelsgesellschaft M.b.h.

patent

8. 1 out of 76

Pharmacia & Upjohn Ab

Worg Pharmaceuticals (Zhejiang) Co., Ltd.

patents

12. 2 out of 834,601

Other

patents

Years Active: 1996-2023

Loading Chart...

Areas of Expertise:

Allergy Vaccines

Hypoallergenic Polypeptides

HIV Detection

House Dust Mite

Grass Pollen

Mosaic Antigens

Peptide Carriers

Non-Anaphylactic Forms

Recombinant Allergens

Rhinovirus Diagnosis

Antibody Detection

Birch Pollen

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11771760 - Treatment and prevention of house dust mite allergies (2023-10-03),

2. 11237166 - Method for detecting HIV-1-specific antibodies using clade C env polypeptides (2022-02-01),

3. 10209257 - Solid support comprising HIV-1 clade C envelope peptides for the detection of HIV-1-specific antibodies (2019-02-19),

4. 9963489 - House dust mite allergen (2018-05-08),

5. 9844591 - Peptide carrier fusion proteins as allergy vaccines (2017-12-19),

6. 9638694 - Method for diagnosing a rhinovirus infection (2017-05-02),

7. 9308251 - Peptide carrier fusion proteins as allergy vaccines (2016-04-12),

8. 9296828 - Vaccine carrier (2016-03-29),

9. 9238062 - Hypoallergenic polypeptides for the treatment of house dust mite allergy (2016-01-19),

10. 9173934 - Wheat allergens (2015-11-03),

11. 9103835 - Hypoallergenic hybrid polypeptides for the treatment of allergy (2015-08-11),

12. 8709435 - Hypallergenic mosaic antigens and methods of making same (2014-04-29),

13. 8454964 - Microparticles comprising carbohydrate beads covalently linked with allergen (2013-06-04),

14. 8440200 - Non-anaphylactic forms of grass pollen Ph1 p 6 allergen and their use (2013-05-14),

15. RE42324 - Compound for treatment of allergy and asthma (2011-05-02),

Title: Rudolf Valenta: Pioneering Inventor from Theresienfeld

Introduction: Rudolf Valenta is a distinguished inventor hailing from Theresienfeld, Austria, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Rudolf Valenta holds several patents in various technological domains, showcasing his continuous commitment to pushing the boundaries of innovation.

Career Highlights: Throughout his illustrious career, Rudolf Valenta has been instrumental in developing cutting-edge technologies that have revolutionized industries and improved the quality of life for many.

Collaborations: Rudolf Valenta has collaborated with leading research institutions, universities, and innovative companies to bring his visionary ideas to life, fostering a culture of creativity and progress.

Conclusion: Rudolf Valenta's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, inspiring the next generation of innovators to dream big and push the limits of what is possible.

Profile summary based on public USPTO records.